Holen Sie sich die Stockscreener-App
74.98
2.69%
-2.07
Handel nachbörslich:
75.01
0.03
+0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$77.05
Offen:
$76.57
24-Stunden-Volumen:
10.82M
Relative Volume:
1.87
Marktkapitalisierung:
$60.60B
Einnahmen:
$20.10B
Nettoeinkommen (Verlust:
$3.04B
KGV:
21.01
EPS:
3.569
Netto-Cashflow:
$3.37B
1W Leistung:
-3.66%
1M Leistung:
-3.87%
6M Leistung:
-17.13%
1J Leistung:
-19.66%
1-Tages-Spanne:
$74.55
$76.80
1-Wochen-Bereich:
$74.55
$77.79
52-Wochen-Spanne:
$74.55
$100.18
Colgate Palmolive Co Stock (CL) Company Profile
Firmenname
Colgate Palmolive Co
Sektor
Telefon
(212) 310-2000
Adresse
300 PARK AVE, NEW YORK, NY
Vergleichen Sie CL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
74.98 | 62.11B | 20.10B | 3.04B | 3.37B | 3.569 |
|
PG
Procter Gamble Co
|
148.02 | 351.37B | 84.93B | 16.86B | 14.94B | 6.8506 |
|
UL
Unilever Plc Adr
|
60.67 | 147.58B | 64.99B | 6.71B | 6.53B | 2.4355 |
|
KMB
Kimberly Clark Corp
|
102.27 | 39.73B | 18.08B | 1.81B | 2.10B | 5.904 |
|
KVUE
Kenvue Inc
|
16.14 | 27.58B | 15.14B | 1.42B | 1.63B | 0.7361 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Fortgesetzt | Piper Sandler | Neutral |
| 2024-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2024-09-24 | Eingeleitet | Piper Sandler | Overweight |
| 2024-09-16 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-09-09 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-07-23 | Eingeleitet | TD Cowen | Buy |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-03-01 | Fortgesetzt | Goldman | Buy |
| 2024-01-29 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-13 | Eingeleitet | Jefferies | Buy |
| 2023-10-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-09-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-02-17 | Eingeleitet | Citigroup | Buy |
| 2023-01-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-22 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-10-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-01 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-05-03 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-04-08 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-02-02 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-01-31 | Bestätigt | Citigroup | Neutral |
| 2022-01-31 | Bestätigt | Credit Suisse | Outperform |
| 2022-01-31 | Bestätigt | Deutsche Bank | Buy |
| 2022-01-31 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-31 | Bestätigt | Wells Fargo | Underweight |
| 2021-12-16 | Eingeleitet | Redburn | Neutral |
| 2021-10-05 | Fortgesetzt | BofA Securities | Neutral |
| 2021-09-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-06-24 | Eingeleitet | UBS | Buy |
| 2021-06-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-02-01 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2021-01-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-01-26 | Hochstufung | Berenberg | Sell → Hold |
| 2021-01-20 | Eingeleitet | Bernstein | Underperform |
| 2021-01-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-07-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-03-27 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-27 | Hochstufung | SunTrust | Hold → Buy |
| 2020-03-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-03 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-02-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-12-19 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-10-16 | Eingeleitet | Berenberg | Sell |
| 2019-04-29 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-07 | Eingeleitet | Credit Suisse | Underperform |
| 2019-02-11 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2019-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2019-01-09 | Hochstufung | Goldman | Neutral → Buy |
| 2018-10-29 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Herabstufung | SunTrust | Buy → Hold |
| 2018-07-30 | Herabstufung | Macquarie | Outperform → Neutral |
| 2018-05-25 | Hochstufung | Argus | Hold → Buy |
| 2018-04-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Colgate Palmolive Co Aktie (CL) Neueste Nachrichten
CL: UBS Lowers Price Target for Colgate-Palmolive to $90 | CL St - GuruFocus
Colgate-Palmolive plans agentic AI push in pursuit of growth - CIO Dive
Colgate-Palmolive (CL) Target Price Lowered by Citigroup's Lates - GuruFocus
Colgate-Palmolive Analysts Cut Their Forecasts After Q3 Earnings - Benzinga
Colgate-Palmolive (CL) Price Target Lowered by Morgan Stanley | - GuruFocus
Colgate-Palmolive’s Third-Quarter Results Miss The Mark - Finimize
Revenue growth for Colgate-Palmolive thanks to higher prices - RetailDetail EU
JP Morgan Lowers Price Target for Colgate-Palmolive (CL) to $87 - GuruFocus
Colgate-Palmolive Faces Consumer Spending Squeeze - AD HOC NEWS
Colgate-Palmolive (CL) Receives Lower Price Target from Evercore ISI | CL Stock News - GuruFocus
Wells Fargo Maintains Underweight Rating on Colgate-Palmolive (C - GuruFocus
5,634 Shares in Colgate-Palmolive Company $CL Bought by Accuvest Global Advisors - MarketBeat
Sumitomo Life Insurance Co. Has $2.20 Million Holdings in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Sees Q3 Sales Surge: Higher Pricing Counters Volume Decline - Retail News Asia
Colgate-Palmolive posts Q3 sales growth amid higher pricing - Inside FMCG
Colgate-Palmolive Stock Still Finds Bullish Retail Support After Signaling Consumer Fatigue With Sluggish Outlook - MSN
Colgate's sore about cavity in India growth curve - The Economic Times
Corporate Actions This Week: Colgate, Coal India And HPCL In Focus - NDTV Profit
Combining price and volume data for Colgate Palmolive Company2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
Colgate-Palmolive (NYSE:CL) Announces Quarterly Earnings Results - MarketBeat
Colgate (CL) Q3 2025 Earnings Call Transcript - The Globe and Mail
Colgate-Palmolive Co. Stock Plummets to 52-Week Low of $75.38 - Markets Mojo
Lockheed Martin Investment Management Co. Buys Shares of 26,100 Colgate-Palmolive Company $CL - MarketBeat
Is Colgate Palmolive Company stock near bottom after declineInflation Watch & AI Forecasted Stock Moves - newser.com
Colgate-Palmolive (CL): Margin Expansion Strengthens Case for Undervaluation Versus Community Narrative - Yahoo! Finance UK
Decoding Colgate-Palmolive Co (CL): A Strategic SWOT Insight - GuruFocus
Colgate-Palmolive Co. (CL) Sees Decline in Gross Profit Margin - GuruFocus
Research Alert: CFRA Keeps Hold View On Shares Of Colgate-palmolive Company - 富途牛牛
Colgate-Palmolive Co (CL) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Colgate-Palmolive Q3 2025 Earnings Call Transcript - MarketBeat
Colgate-Palmolive Boosts Promotions to Offset Price Hikes - The Wall Street Journal
Colgate-Palmolive Lowers Sales Outlook As Shoppers Trade Down - Finimize
Colgate-Palmolive posts higher Q3 sales as pricing gains offset volume decline - CryptoRank
Net Sales Grow 2% for Colgate-Palmolive in Q3 2025 - Happi | Household And Personal Products Industry
Colgate-Palmolive Cuts Annual Sales Forecast On Signs Of Sluggish Demand - ESM Magazine
Colgate Flexes Toothpaste Crown But Stock Hits 52-week low - Benzinga
Colgate-Palmolive Q2 2025 slides reveal innovation push and productivity program - Investing.com Australia
Colgate-Palmolive Faces Sluggish Urban Demand in India - scanx.trade
Colgate-Palmolive trims FY25 sales growth outlook to reflect 'uncertainty in global markets' (CL:NYSE) - Seeking Alpha
Colgate-Palmolive cuts annual sales forecast on signs of sluggish demand By Reuters - Investing.com
Colgate-Palmolive Co (CL) Q3 2025 Earnings: EPS of $0.91 Beats E - GuruFocus
Colgate-Palmolive lowers full-year sales outlook, Q3 earnings top estimates - Investing.com Nigeria
Colgate-Palmolive Reaffirms FY25 EPS, Adj. EPS And Organic Sales Growth OutlookUpdate - Nasdaq
Colgate-Palmolive (NYSE:CL) Reports Q3 In Line With Expectations - Yahoo! Finance UK
Colgate-Palmolive Beats Estimates, Maintains Full-Year Guidance - Bloomberg.com
Colgate-Palmolive: Q3 Earnings Snapshot - San Antonio Express-News
Colgate-Palmolive earnings beat by $0.02, revenue was in line with estimates - Investing.com Nigeria
Colgate-Palmolive's Q3 net sales up 2% to $5.1B - breakingthenews.net
Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
Large Dividends: Shree Cement, Colgate Palmolive, Oracle Financial — Last Day To Buy Shares To Qualify - NDTV Profit
Colgate Palmolive (CL) Set to Announce Earnings - GuruFocus
Finanzdaten der Colgate Palmolive Co-Aktie (CL)
Umsatz
Nettogewinn
Free Cashflow
ENV
14.57%
12.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):